Prognostic Factor Studies

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-03-26

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1201/B11800-30
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An introduction to neural networks

  2018cited by this paper
• An overview of techniques for linking high‐dimensional molecular data to time‐to‐event endpoints by risk prediction models

  2011cited by this paper
• Analysis of randomized comparative clinical trial data for personalized treatment selections.

  2011cited by this paper
• Sparse regression techniques in low-dimensional survival data settings

  2010cited by this paper
• Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.

  2010cited by this paper
• Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.

  2010cited by this paper
• High-Dimensional Variable Selection for Survival Data

  2010cited by this paper
• High‐Dimensional Cox Models: The Choice of Penalty as Part of the Model Building Process

  2010cited by this paper
• A general, prediction error‐based criterion for selecting model complexity for high‐dimensional survival models

  2010cited by this paper
• The evaluation of clinical predictions. A method and initial application.

  2010cited by this paper
• Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures

  2010cited by this paper
• Prognosis and prognostic research: Developing a prognostic model

  2009cited by this paper
• Prognosis and prognostic research: what, why, and how?

  2009cited by this paper
• Prognosis and prognostic research: application and impact of prognostic models in clinical practice

  2009cited by this paper
• Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

  2009cited by this paper
• Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

  2009cited by this paper
• Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

  2009cited by this paper
• Prognosis and prognostic research: validating a prognostic model

  2009cited by this paper
• The Performance of Risk Prediction Models

  2008cited by this paper
• Chapter 13. Systematic Reviews of Evaluations of Prognostic Variables

  2008cited by this paper
• BMC Bioinformatics BioMed Central Methodology article Empirical Bayes analysis of single nucleotide polymorphisms

  2008cited by this paper
• Interactions between treatment and continuous covariates: a step toward individualizing therapy.

  2008cited by this paper
• Implementing a Class of Permutation Tests: The coin Package

  2008cited by this paper
• Shaping the future of biomarker research in breast cancer to ensure clinical relevance

  2007cited by this paper
• Relaxing the rule of ten events per variable in logistic and Cox regression.

  2007cited by this paper
• BMJ: British Medical Journal

  2007cited by this paper
• Selection of important variables and determination of functional form for continuous predictors in multivariable model building

  2007cited by this paper
• Modelling to extract more information from clinical trials data: On some roles for the bootstrap

  2007cited by this paper
• Assessment of survival prediction models based on microarray data

  2007cited by this paper
• Almost all articles on cancer prognostic markers report statistically significant results.

  2007cited by this paper
• Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

  2007cited by this paper
• Predicting survival from microarray data - a comparative study

  2007cited by this paper
• Boosting Algorithms: Regularization, Prediction and Model Fitting. Rejoinder.

  2007cited by this paper
• Detecting an interaction between treatment and a continuous covariate: A comparison of two approaches

  2007cited by this paper
• CAN ONE ESTIMATE THE UNCONDITIONAL DISTRIBUTION OF POST-MODEL-SELECTION ESTIMATORS?

  2007cited by this paper
• Statistics in medicine--reporting of subgroup analyses in clinical trials.

  2007cited by this paper
• Boosting ridge regression

  2007cited by this paper
• Efron‐Type Measures of Prediction Error for Survival Analysis

  2007cited by this paper
• Dichotomizing continuous predictors in multiple regression: a bad idea

  2006cited by this paper
• Estimating the functional form of a continuous covariate's effect on survival time

  2006cited by this paper
• The Adaptive Lasso and Its Oracle Properties

  2006cited by this paper
• Evidence-Based Assessment and Application of Prognostic Markers: The Long Way from Single Studies to Meta-Analysis

  2006cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• Neural network models for breast cancer prognosis

  2005cited by this paper
• Roadmap for developing and validating therapeutically relevant genomic classifiers.

  2005cited by this paper
• Individual survival time prediction using statistical models

  2005cited by this paper
• The Nottingham prognostic index in primary breast cancer

  2005cited by this paper
• A practical application of neural network analysis for predicting outcome of individual breast cancer patients

  2005cited by this paper
• Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

  2005cited by this paper
• A demonstration that breast cancer recurrence can be predicted by Neural Network analysis

  2005cited by this paper
• Integrating prognostic factors

  2005cited by this paper
• Counting Processes and Survival Analysis: Fleming/Counting

  2005cited by this paper
• A Comparison of Nonparametric Error Rate Estimation Methods in Classification Problems

  2004cited by this paper
• Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint

  2004cited by this paper
• Survival analysis of censored data: Neural network analysis detection of complex interactions between variables

  2004cited by this paper
• Patterns of treatment effects in subsets of patients in clinical trials.

  2004cited by this paper
• A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

  2004cited by this paper
• Bagging survival trees

  2004cited by this paper
• Non‐linear survival analysis using neural networks

  2004cited by this paper
• A new measure of prognostic separation in survival data

  2004cited by this paper
• The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)

  2004cited by this paper
• Validation of existing and development of new prognostic classification schemes in node negative breast cancer

  2004cited by this paper
• Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation

  2003cited by this paper
• How to Assess Prognostic Models for Survival Data: A Case Study in Oncology

  2003cited by this paper
• On the exact distribution of maximally selected rank statistics

  2003cited by this paper
• Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

  2003cited by this paper
• Statistical Methods for Survival Data Analysis: Lee/Survival Data Analysis

  2003cited by this paper
• A general framework for neural network models on censored survival data

  2002cited by this paper
• The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration

  2001cited by this paper
• Random Forests

  2001cited by this paper
• Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)

  2001cited by this paper
• A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data.

  2000cited by this paper
• An Experimental Comparison of Three Methods for Constructing Ensembles of Decision Trees: Bagging, Boosting, and Randomization

  2000cited by this paper
• Subgroup analysis and other (mis)uses of baseline data in clinical trials.

  2000cited by this paper
• Sample size considerations for the evaluation of prognostic factors in survival analysis.

  2000cited by this paper
• Predictive Accuracy and Explained Variation in Cox Regression

  2000cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology.

  2000cited by this paper
• R2: a useful measure of model performance when predicting a dichotomous outcome.

  1999cited by this paper
• Multiple imputation of missing blood pressure covariates in survival analysis.

  1999cited by this paper
• Assessment and comparison of prognostic classification schemes for survival data.

  1999cited by this paper
• Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials

  1999cited by this paper
• Modelling the effects of standard prognostic factors in node-positive breast cancer

  1999cited by this paper
• The Use of Resampling Methods to Simplify Regression Models in Medical Statistics

  1999cited by this paper
• Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach.

  1998cited by this paper
• Estimating equations with incomplete categorical covariates in the Cox model.

  1998cited by this paper
• The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index

  1998cited by this paper
• Some issues in estimating the effect of prognostic factors from incomplete covariate data.

  1997cited by this paper
• Resampling and cross-validation techniques: a tool to reduce bias caused by model building?

  1997cited by this paper
• The lasso method for variable selection in the Cox model.

  1997cited by this paper
• Neural Networks in Clinical Medicine

  1996cited by this paper
• Explained variation in survival analysis.

  1996cited by this paper
• RANDOMIZED AND NON‐RANDOMIZED PATIENTS IN CLINICAL TRIALS: EXPERIENCES WITH COMPREHENSIVE COHORT STUDIES

  1996cited by this paper
• Neural networks and logistic regression: Part I

  1996cited by this paper
• Evaluating the effect of optimized cutoff values in the assessment of prognostic factors

  1996cited by this paper
• Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model.

  1996cited by this paper
• Neural networks in applied statistics

  1996cited by this paper
• Practical p-value adjustment for optimally selected cutpoints.

  1996cited by this paper
• Commentary: Prognostic models: clinically useful or quickly forgotten?

  1995cited by this paper

• Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer

  2020cites this paper
• High-Dimensional Covariates in the Joint Frailty-Copula Model

  2019cites this paper
• Prognostic models for breast cancer: a systematic review

  2019cites this paper
• and Kurt Hornik Evaluating Model-based Trees in Practice

  2017cites this paper
• The Multivariable Fractional Polynomial Approach , with Thoughts about Opportunities and Challenges in Big Data

  2016cites this paper
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and

  2015cites this paper
• Reasons for premature termination of dialectical behavior therapy for inpatients with borderline personality disorder.

  2014cites this paper
• Possible Prognostic Value of BORIS Transcript Variants Ratio in Laryngeal Squamous Cell Carcinomas – a Pilot Study

  2014cites this paper
• K-Adaptive Partitioning for Survival Data, with an Application to Cancer Staging

  2013cites this paper
• Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.

  2012cites this paper
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

  2012cites this paper
• Model complexity selection in high-dimensional time-to-event data analysis

  2011cites this paper
• Phase 3 trial of everolimus for metastatic renal cell carcinoma

  2010cites this paper
• Sparse regression techniques in low-dimensional survival data settings

  2010influential citation